Abstract:Membrane active antimicrobial peptide mimics have been considered as promising alternatives to antibiotics, which interact with bacterial cell membranes to combat bacteria and avoid the emergence of multidrug-resistant bacteria. Herein, a series of star-shaped and membrane-active cationic polyetheramides derived from amino acids, were synthesized via condensation of amino acids and polyetheamine (T403). The antibacterial and anti-biofilm activitives as well as the biocompatibility of these amino acids derived polyetheramides (AAPEAs) were investigated in detail. The star-shaped AAPEAs showed high-efficient and broad-spectrum antibacterial activity against the Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species (ESKAPE) pathogens. In addition, the antibacterial activity was significantly affected by the type of amino acid. L-Trp-T403, which was obtained from L-tryptophan and polyetheramine, exhibited the best antibacterial activity with the minimum inhibitory concentration (MIC) of 1 mu g/mL against methicillin-resistant S. aureus (MRSA). Time-kill kinetics and multi-passage resistance tests experiments indicated that L-Trp-T403 could rapidly kill bacteria within 1 h. This compound also showed potent antibacterial activity against bacteria over many passages. Moreover, the AAPEAs exhibited outstanding stability and long-term antibacterial activity in complex mammalian body fluids, as well as good biocompatibility, low hemolytic activity, slight toxicity for mammalian cell (L929) and low in vivo toxicity. The antibacterial activity of L-Trp-T403 was found to be based on the disruption of bacterial membranes, which leads to the leakage of the internal cytoplasm. The AAPEAs possessed high antibacterial and antibiofilm activity, thus, they are promising to be used as long-term and biofilm-disrupting antimicrobial agents.Statement of significance The growing epidemic of MDR-bacteria is becoming a severe public health threat. Here, a series of amino acids derived polyetheramides (AAPEAs) with a star-shaped polyether amide scaffold was synthesized. The star-shaped AAPEAs displayed broad-spectrum antibacterial activity against Gram-positive, Gramnegative bacteria and drug-resistant bacteria MRSA. Notably, the star-shaped AAPEAs were stable under plasma conditions and showed outstanding stability and long-term antibacterial activity in various complex mammalian fluids. Moreover, these star-shaped AAPEAs not only inhibited the formation of biofilms but also disrupted the established biofilms. Furthermore, the membrane-active AAPEAs eradicated bacteria via the fast membrane lytic mechanism, thus plausibly overcoming the MDR effect. These results demonstrate that membrane-active AAPEAs can serve as emerging long-term and biofilm-disrupting antimicrobial agents to treat biofilm-related infections.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Antimicrobial activity of the BAM complex-targeting peptides against multidrug-resistant gram-negative bacteria

The discovery and structural basis of two distinct state-dependent inhibitors of BamA

BamA-targeted antimicrobial peptide design for enhanced efficacy and reduced toxicity

A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier

Antibiotics that Kill Gram-negative Bacteria by Restructuring the Outer Membrane Protein BamA

A Targeted Boost-and-sort Immunization Strategy Using Escherichia Coli BamA Identifies Rare Growth Inhibitory Antibodies

Membrane-active and DNA Binding Related Double-Action Antimycobacterial Mechanism of Antimicrobial Peptide W3R6 and Its Synthetic Analogs

Cationic Amphipathic D-enantiomeric Antimicrobial Peptides with in Vitro and Ex Vivo Activity Against Drug-Resistant Mycobacterium Tuberculosis.

N-Lipidated Peptide Dimers: Effective Antibacterial Agents Against Gram-Negative Pathogens Through Lipopolysaccharide Permeabilization

Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities

Inhibitors targeting BamA in gram-negative bacteria

Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens

Antimicrobial and Anti-Inflammatory Activities of MAF-1-Derived Antimicrobial Peptide Mt6 and Its D-Enantiomer D-Mt6 against Acinetobacter baumannii by Targeting Cell Membranes and Lipopolysaccharide Interaction

ATP‐independent assembly machinery of bacterial outer membranes: BAM complex structure and function set the stage for next‐generation therapeutics

Monoclonal Antibody Targeting the Β-Barrel Assembly Machine of Escherichia Coli is Bactericidal.

Mechanistic Study of Antimicrobial Effectiveness of Cyclic Amphipathic Peptide [R4W4] against Methicillin-Resistant Staphylococcus aureus Clinical Isolates

Membrane-active Amino Acid-Coupled Polyetheramine Derivatives with High Selectivity and Broad-Spectrum Antibacterial Activity

Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens

Functional and toxicological evaluation of the MAA-41: a novel rationally designed antimicrobial peptide using hybridization and modification methods from LL-37 and BMAP-28.

Unlocking roles of cationic and aromatic residues in peptide amphiphiles in treating drug-resistant gram-positive pathogens

A Short Peptide Derived from Zebrafish AP‐2 Complex Subunit Mu‐a AP2M1A354–382 Has Antimicrobial Activity Against Multi‐drug Resistant Bacteria